Paul Molloy, ClearFlow’s CEO has participated in two successful IPO’s (one he led as CEO in 2005 & exited three of his last four firms as CEO and participated in exits at the Board level in several other MedTech firms in the last decade (including NASDAQ listed CASMed to Edwards Life Sciences and Revolutionary Medical Devices to Vyair). He is presently on the Board at ClearFlow, Inc. and Augustine Medical (a temperature management company founded by Scott Augustine, founder of Bair Hugger FAW). He managed Teleflex’s largest division (Arrow Vascular) from 2011-2013 with a $700M P&L, six US and international manufacturing plants employing over 3,000 staff and a US sales organization of 100 reps. Significant value creation (TFX, NYSE) resulted during this tenure (publicly available filings). Paul was a CRNA in clinical practice, earned a diploma in Hospital Management from the Instituut Der Bedrijfswetenschappen in The Netherlands and holds an MBA from University of Chicago Booth School of Business.